Aspects of Macronutrients in the Development of Prostate Cancer


  • Machmud Aminudin Universitas Lampung
  • Ratna Dewi Puspita Sari
  • Anisa Nuraisa Djausal



Carbohydrates fats, macronutrients, prostate cancer, protein


Prostate cancer is cell growth with an abnormal pattern so that it does not stop growing even though the cell density has been met in the prostate gland. Prostate cancer ranks third as cancer with the highest number and ranks as the cause of death. Prostate cancer risk factors are divided into unmodified such as age, race and genetics and modified such as activity, smoking, and diet. This article is a literature compiled to determine the macronutrient factors, namely carbohydrates, fats, and proteins on the incidence of prostate cancer. The literature sources used in this article use national and international scientific articles published in 2013-2022. Macronutrient carbohydrates and fats have an effect on the development of prostate cancer because they cause body obesity, causing inflammation and oxidative stress that stimulates the development of prostate cancer. While the protein macronutrients have inconsistent results on prostate development. However, consumption of vegetable protein in higher amounts is beneficial for inhibiting the development of prostate cancer because of the antioxidant content in it.


WHO. Cancer Incident in Global 2020. World Health Organization. New York; 2020.

WHO. Cancer Incident in Indonesia 2020. World Health Organization. New York; 2020.

ACS. About Prostate Cancer. American Cancer Society. New York; 2018. 1–15 p.

Liwang F, Yuswar PW, Wijaya E, Sanjaya NP. Kapita Selekta Kedokteran Jilid II. 5th ed. Jakarta: Media Aesculapius; 2020.

Mossine V V., Mawhinney TP, Giovannucci EL. Dried Fruit Intake and Cancer: A Systematic Review of Observational Studies. Adv Nutr. 2020;11(2):237–50.

Damayanti D, Lestari NT. Bahan Ajar Gizi : Gizi Dalam Daur Kehidupan. Jakarta: Kementerian Kesehatan RI; 2017.

Matsushita M, Nonomura N. Influence of diet and nutrition. Int J Molecuar Sci. 2020;21(4):1–18.

Alboghobeish Z, Hosseini Balam F, Askari F, Rashidkhani B. Dietary Carbohydrate Intake Glycemic Index and Glycemic Load and the Risk of Prostate Cancer among Iranian Men: A Case-Control Study. Nutr Cancer. 2022;74(3):882–8.

Miles FL, Neuhouser ML, Zhang ZF. Concentrated Sugars and Incidence of Prostate Cancer in a Prospective Cohort. Br J Nutr. 2018;120(6):1–16.

Matsushita M, Fujita K, Hatano K, De Velasco MA, Uemura H, Nonomura N. Connecting the Dots Between the Gut–IGF-1–Prostate Axis: A Role of IGF-1 in Prostate Carcinogenesis. Front Endocrinol (Lausanne). 2022;13(3):1–8.

Freedland SJ, Howard LE, Ngo A, Torres AR, Czismadi I, Cheng S, et al. Low Carbohydrate Diets and Estimated Cardiovascular and Metabolic Syndrome Risk in Prostate Cancere. J Urol. 2021;206(6):1411–9.

Chi JT, Lin PH, Tolstikov V, Oyekunle T, Alvarado GCG, Torres AR, et al. The influence of low-carbohydrate diets on the metabolic response to androgen-deprivation therapy in prostate cancer Jen-Tsan. Prostate. 2021;81(10):618–28.

Michels N, Specht IO, Heitmann BL, Chajès V, Huybrechts I. Dietary trans-fatty acid intake in relation to cancer risk: A systematic review and meta-analysis. Nutr Rev. 2021;79(7):758–76.

Plaza BL, Bermejo LM, Santurino C, Redondo IC, Bueno CA, Candela CG. Milk and Dairy Product Consumption and Risk of Mortality: An Overview of Systematic Reviews and Meta-Analyses. Adv Nutr. 2019;10:212–23.

Hayashi T, Fujita K, Nojima S, Hayashi Y, Nakano K, Ishizuya Y, et al. High-fat diet-induced inflammation accelerates prostate cancer growth via IL6 signaling. Clin Cancer Res. 2018;24(17):4309–18.

Zhao Y, Wu T, Shao S, Shi B, Zhao Y. Phenotype, development, and biological function of myeloid-derived suppressor cells. Oncoimmunology. 2016;5(2):1–12.

Rossi JF, Lu ZY, Jourdan M, Klein B. Interleukin-6 as a therapeutic target. Clin Cancer Res. 2015;21(6):1248–57.

Bouchery T, Kyle R, Camberis M, Shepherd A, Filbey K, Smith A, et al. ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookworms. Nat Commun. 2015;6:1–13.

Ito Y, Ishiguro H, Kobayashi N, Hasumi H, Watanabe M, Yao M, et al. Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through the induction of MMP-2 activity. Prostate. 2015;75(10):1009–19.

Brouwer IA, Geleijnse JM, Klaasen VM, Smit LA, Giltay EJ, De Goede J, et al. Effect of alpha linolenic acid supplementation on serum Prostate Specific Antigen (PSA): Results from the alpha omega trial. PLoS One. 2013;8(12):8–13.

Moreel X, Allaire J, Léger C, Caron A, Labonté MÈ, Lamarche B, et al. Prostatic and dietary omega-3 fatty acids and prostate cancer progression during active surveillance. Cancer Prev Res. 2014;7(7):766–76.

Diana FM. Omega 3. J Kesehat Masy. 2012;6(2):113–7.

Mao Y, Tie Y, Du J. Association between dietary protein intake and prostate cancer risk: Evidence from a meta-analysis. World J Surg Oncol. 2018;16(1):1–10.

Alzahrani MA, Shakil Ahmad M, Alkhamees M, Aljuhayman A, Binsaleh S, Tiwari R, et al. Dietary protein intake and prostate cancer risk in adults: A systematic review and dose-response meta-analysis of prospective cohort studies. Complement Ther Med. 2022;70:1–11.

Bellamri M, Walmsley SJ, Turesky RJ. Metabolism and biomarkers of heterocyclic aromatic amines in humans. Genes Environ. 2021;43(1):1–32.

Raux A, Bichon E, Benedetto A, Pezzolato M, Bozzetta E, Le Bizec B, et al. The Promise and Challenges of Determining Recombinant Bovine Growth Hormone in Milk. Foods. 2022;11(3):1–13.

Kimanya ME, Routledge MN, Mpolya E, Ezekiel CN, Shirima CP, Gong YY. Estimating the risk of aflatoxin-induced liver cancer in Tanzania based on biomarker data. PLoS One. 2021;16(3):1–11.

Levine ME, Suarez JA, Brandhorst S, Balasubramanian P, Cheng CW, Madia F, et al. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab. 2014;19(3):407–17.

Biet SMS, McMahon AC, Ballard JWO, Ruohonen K, Wu LE, Cogger VC, et al. The Ratio of Macronutrients, Not Caloric Intake, Dictates Cardiometabolic Health, Aging, and Longevity in Ad Libitum-Fed Mice. Cell Metab. 2014;19(3):1–22.

Zhai X, Lin M, Zhang F, Hu Y, Xu X, Li Y, et al. Dietary flavonoid genistein induces Nrf2 and phase II detoxification gene expression via ERKs and PKC pathways and protects against oxidative stress in Caco-2 cells. Mol Nutr Food Res. 2013;57(2):249–59.

Mahmoud AM, Yang W, Bosland MC. Soy Isoflavones and Prostate Cancer: A Review of Molecular Mechanisms. J Steroid Biochem Mol Biol. 2014;140:116–32.



How to Cite

Machmud Aminudin, Ratna Dewi Puspita Sari, & Anisa Nuraisa Djausal. (2023). Aspects of Macronutrients in the Development of Prostate Cancer. Medical Profession Journal of Lampung, 12(3), 531-536.